New Study Tests Effectiveness of High-Intensity Exercise in Slowing Parkinson’s Symptoms
The University of Florida is collaborating on a new Phase 3 multisite clinical trial that will test the effectiveness of high-intensity and moderate-intensity treadmill exercise in slowing the progression of Parkinson’s disease symptoms.
New Test Would Use DNA to Find Brain Tumors, Cancer
It’s being called a major breakthrough in the fight against cancer. Researchers have developed a blood test that can detect brain tumors early, but that’s not the only thing this new test can do. Brain cancer: Two words no one ever wants to hear, but for those who do, “Remarkable resilience is something that we […]
UF Researchers Help Lead International Studies Into Two Rare Neuromuscular Disorders
Researchers at the University of Florida are partnering with colleagues from top peer institutions to advance the understanding of two rare hereditary neuromuscular disorders — Friedreich’s ataxia and Facioscapulohumeral Muscular Dystrophy, or FSHD, both of which typically lead to the need for a wheelchair by young adulthood. A UF team led by neurologist S.H. Subramony, […]
MBI Directors Discuss Alzheimer’s Research and Care
On Wednesday, Sept. 23, 2020, UF Health hosted a webinar titled, “Alzheimer’s: Help for today and hope for tomorrow,” featuring Todd Golde, M.D., Ph.D., MBI director, and Steven DeKosky, M.D., MBI deputy director. The webinar touched on the past, present and future of Alzheimer’s disease research as well as information about care and medications. Following the presentation, […]
UF Neuroscientists Find Sex Hormones May Influence Risk Taking, Impulsivity in Rats
New research by University of Florida neuroscientists suggests that male and female sex hormones may play differing roles in risk-taking inclinations and the ability to delay gratification. The findings from two separate rodent-model studies, reported in the journals Neuropsychopharmacology and eLife, could provide useful insight for the development of future treatment approaches for psychiatric conditions […]
New Trial Drug Combination Shows Promise for Slowing Progression of ALS
A new drug combination tested in a multisite human clinical trial shows promise for slowing the progression of ALS, often called Lou Gehrig’s disease, researchers at the University of Florida and partner institutions reported in The New England Journal of Medicine. The oral drug, a combination of sodium phenylbutyrate and taurursodiol, was tested in the […]
The Importance of Blood Tests for Alzheimer’s: UF Neuroscientists Explain the Recent Findings
University of Florida neuroscientists Steven DeKosky, MD, and Todd Golde, MD, Ph.D., announced new findings on a blood test to diagnose Alzheimer’s disease at the Alzheimer’s Association International Conference on July 29, 2020. The test showed extremely high accuracy – around 90% – for detecting chemicals in the blood that are specific for Alzheimer’s. Those […]
UF Neurologists Create a New Image of Parkinson Disease
An outdated sketch from 1886 by Sir William Richard Gowers remains among the most used and viewed depictions of Parkinson disease, despite great advancements in the understanding of the neurological disorder. Now, UF neurologists Melissa Armstrong, M.D. and Michael S. Okun, M.D. have worked with a medical illustrator to create a new, more diverse representation of who is affected by […]
New Study Demonstrates the Brain’s Ability to Shift and Utilize Different Neural Circuits
A new study by UF neuroscientists demonstrates an example of the brain’s ability to shift and utilize different neural circuits to perform a task in order to compensate for brain aging. The rat model study, published recently in the Journal of Neuroscience, was designed to test the hypothesis that cognitive impairments due to the aging […]
UF Investigators Earn Michael J. Fox Foundation Award
Investigators at UF’s Center for Translational Research in Neurodegenerative Disease, or CTRND, earned a one-year, $200,000 award from the Michael J. Fox Foundation’s Target Advancement Program to explore novel approaches to treat Parkinson’s disease. “We hope that this study will help us understand more about the role of CB2 in brain immune cells to remove […]